
A review conducted by INESSS highlights the barriers and facilitators to the implementation of digital health solutions, as well as frameworks used for evaluating these technologies. The consultation with patients and citizens highlights issues such as equity of access, accessibility and security of personal health data, and training and support of users. The study shows the heterogeneity of approaches underlying their assessment in practice and emphasizes the need for strategies tailored to users’ needs.
Recent Posts
Rare Medications Coverage in the Netherlands: Price Reductions Required
Zorginstituut Nederland has announced that two rare disease medications, exagamglogene autotemcel (Casgevy®) and omaveloxolon (Skyclarys®), will only be covered by Dutch basic health insurance if their prices drop significantly. For omaveloxolon, treating Friedreich's ataxia, an 84% price cut is ...
Sanofi’s Rilzabrutinib Receives Orphan Designation for IgG4-Related Disease
Sanofi's rilzabrutinib has received orphan drug designation from the European Medicines Agency for treating IgG4-related disease (IgG4-RD). This reversible covalent Bruton's tyrosine kinase (BTK) inhibitor earned the designation based on promising Phase 2 study results. The findings, presented at...
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System Impacts
Urgent care effectiveness has become a central question for Canada’s health systems as policymakers look for tangible ways to relieve emergency department (ED) overcrowding and improve timely access to care. Many people want to know: Do urgent care centres actually help reduce pressure on hospita...